Literature DB >> 8662694

Inhibition of mitochondrial function by interferon.

J A Lewis1, A Huq, P Najarro.   

Abstract

We showed previously that type I interferon causes a down-regulation of mitochondrial gene expression. We show here that IFN treatment leads to functional impairment of mitochondria. Western blot analysis indicated that interferon treatment reduces the steady-state level of cytochrome b in murine L-929 cells. Interferon produced a reduction in cytochrome c oxidase and NADH-cytochrome c reductase activities of isolated mitochondria as well as inhibiting electron transport in isolated mitochondria and in intact cells. Several mitochondrial mRNAs are affected by interferon treatment in human Daudi lymphoblastoid cells, which are highly sensitive to the antiproliferative effects of interferon. Electron transport in Daudi cells was also inhibited by interferon both in intact cells and isolated mitochondria with a dose response identical to that for the antiproliferative response. In contrast, a Daudi strain resistant to the antiproliferative effects of interferon showed no down-regulation of mRNA expression and no inhibition of electron transport. Possibly as a consequence of the inhibitory effect on mitochondrial gene expression, treatment with interferon causes a reduction in cellular ATP levels. The inhibition of cellular growth by interferon may thus be partly a consequence of a reduction in cellular ATP levels.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8662694     DOI: 10.1074/jbc.271.22.13184

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  PRDM16 represses the type I interferon response in adipocytes to promote mitochondrial and thermogenic programing.

Authors:  Megan Kissig; Jeff Ishibashi; Matthew J Harms; Hee-Woong Lim; Rachel R Stine; Kyoung-Jae Won; Patrick Seale
Journal:  EMBO J       Date:  2017-04-13       Impact factor: 11.598

2.  DNA damage signaling and p53-dependent senescence after prolonged beta-interferon stimulation.

Authors:  Olga Moiseeva; Frédérick A Mallette; Utpal K Mukhopadhyay; Adrian Moores; Gerardo Ferbeyre
Journal:  Mol Biol Cell       Date:  2006-01-25       Impact factor: 4.138

Review 3.  Interferon alpha: The key trigger of type 1 diabetes.

Authors:  Angela Lombardi; Effie Tsomos; Sara S Hammerstad; Yaron Tomer
Journal:  J Autoimmun       Date:  2018-08-14       Impact factor: 7.094

Review 4.  Multi-tasking: nuclear transcription factors with novel roles in the mitochondria.

Authors:  Karol Szczepanek; Edward J Lesnefsky; Andrew C Larner
Journal:  Trends Cell Biol       Date:  2012-06-14       Impact factor: 20.808

Review 5.  Diverse functions of RNase L and implications in pathology.

Authors:  Catherine Bisbal; Robert H Silverman
Journal:  Biochimie       Date:  2007-02-20       Impact factor: 4.079

Review 6.  The role of phosphometabolites in cell proliferation, energy metabolism, and tumor therapy.

Authors:  S Mazurek; C B Boschek; E Eigenbrodt
Journal:  J Bioenerg Biomembr       Date:  1997-08       Impact factor: 2.945

7.  Role of ribonuclease L in viral pathogen-associated molecular pattern/influenza virus and cigarette smoke-induced inflammation and remodeling.

Authors:  Yang Zhou; Min-Jong Kang; Babal Kant Jha; Robert H Silverman; Chun Geun Lee; Jack A Elias
Journal:  J Immunol       Date:  2013-08-02       Impact factor: 5.422

Review 8.  Diphosphoinositol polyphosphates: metabolic messengers?

Authors:  Stephen B Shears
Journal:  Mol Pharmacol       Date:  2009-05-13       Impact factor: 4.436

9.  L-carnitine treatment reduces steatosis in patients with chronic hepatitis C treated with alpha-interferon and ribavirin.

Authors:  Marcello Romano; Marco Vacante; Erika Cristaldi; Valentina Colonna; Maria Pia Gargante; Lisa Cammalleri; Mariano Malaguarnera
Journal:  Dig Dis Sci       Date:  2007-10-16       Impact factor: 3.199

10.  STAT1 Dissociates Adipose Tissue Inflammation From Insulin Sensitivity in Obesity.

Authors:  Aaron R Cox; Natasha Chernis; David A Bader; Pradip K Saha; Peter M Masschelin; Jessica B Felix; Robert Sharp; Zeqin Lian; Vasanta Putluri; Kimal Rajapakshe; Kang Ho Kim; Dennis T Villareal; Reina Armamento-Villareal; Huaizhu Wu; Cristian Coarfa; Nagireddy Putluri; Sean M Hartig
Journal:  Diabetes       Date:  2020-09-29       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.